Careteq Completes Sale of Embedded Health Unit to Fund Platform Growth and Strengthen Balance SheetTip Ranks·Apr 8 at 11:44 PMLABU-0.76%SBIO+0.52%
Carasent Sets 14 April Date for Q1 2026 Results and WebcastTip Ranks·Apr 8 at 07:40 AMIBBQ-0.58%SBIO+0.52%
Carma issues new shares under employee incentive plan and confirms complianceTip Ranks·Mar 29 at 11:19 PMLABU-0.76%XLV-1.04%
Carma Director Owen Wilson Lifts Stake with On-Market Share PurchasesTip Ranks·Mar 4 at 01:59 AMCARM-22.22%CMA0.00%
Carasent Nomination Committee Proposes Unchanged Board Line-Up for 2026 AGMTip Ranks·Feb 6 at 01:32 PMPBE-1.10%SBIO+0.52%
Cara Therapeutics initiates 1-for-3 reverse stock split amid merger with Tvardi Therapeutics, effective per Board approval.Unusual Whales·Apr 14, 2025 at 04:07 PMCARA0.00%
Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi TherapeuticsGlobeNewswire·Apr 14, 2025 at 03:50 PMCARA0.00%TVRD+3.24%
12:02 ET SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholdersprnewswire·Feb 21, 2025 at 05:03 PMCYTH0.00%CARA0.00%
14:46 ET SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ML, PWOD, NURO, CARA on Behalf of Shareholdersprnewswire·Jan 7, 2025 at 07:47 PMML0.00%NURO0.00%
